跳至主要内容
临床试验/CTRI/2023/06/053700
CTRI/2023/06/053700尚未招募不适用

To assess the efficacy of inj nalbuphine as an adjuvant to intrathecal bupivacaine anaesthetic in endoscopic urological surgeries for prolongation of post operative analgesia.

Datta Meghe Institute of Higher Education and Research1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年6月18日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
The addition of adjuvant 1.5 mg Nalbuphine prolongs the duration of post operative analgesia

研究概览

简要总结

The aim of the study is to compare the efficacy of the addition of intrathecal injection nalbuphine as an adjucant Bupivacaine with intrathecal injection Bupivacaine alone for analgesia in endoscopic urological studies.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
25.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients undergoing urological surgeries,duration 1-3 hours.ASA I and II, MPC I and II.

排除标准

  • Lack of valid consent,ASA grade III and IV, patient with neurological disorder,bleeding disorder,patients on anticoagulants,infection at block site.

结局指标

主要结局

The addition of adjuvant 1.5 mg Nalbuphine prolongs the duration of post operative analgesia

时间窗: post operative 24 hours

次要结局

  • Compare effects on Hemodynamic parameters,onset and suration of sensory and motor block,side effects if any(2 hours post operative)

研究者

发起方
Datta Meghe Institute of Higher Education and Research
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验